Back to Search Start Over

TRPM2 Mediates Neutrophil Killing of Disseminated Tumor Cells.

Authors :
Gershkovitz M
Caspi Y
Fainsod-Levi T
Katz B
Michaeli J
Khawaled S
Lev S
Polyansky L
Shaul ME
Sionov RV
Cohen-Daniel L
Aqeilan RI
Shaul YD
Mori Y
Karni R
Fridlender ZG
Binshtok AM
Granot Z
Source :
Cancer research [Cancer Res] 2018 May 15; Vol. 78 (10), pp. 2680-2690. Date of Electronic Publication: 2018 Feb 28.
Publication Year :
2018

Abstract

Neutrophils play a critical role in cancer, with both protumor and antitumor neutrophil subpopulations reported. The antitumor neutrophil subpopulation has the capacity to kill tumor cells and limit metastatic spread, yet not all tumor cells are equally susceptible to neutrophil cytotoxicity. Because cells that evade neutrophils have greater chances of forming metastases, we explored the mechanism neutrophils use to kill tumor cells. Neutrophil cytotoxicity was previously shown to be mediated by secretion of H <subscript>2</subscript> O <subscript>2</subscript> We report here that neutrophil cytotoxicity is Ca <superscript>2+</superscript> dependent and is mediated by TRPM2, a ubiquitously expressed H <subscript>2</subscript> O <subscript>2</subscript> -dependent Ca <superscript>2+</superscript> channel. Perturbing TRPM2 expression limited tumor cell proliferation, leading to attenuated tumor growth. Concomitantly, cells expressing reduced levels of TRPM2 were protected from neutrophil cytotoxicity and seeded more efficiently in the premetastatic lung. Significance: These findings identify the mechanism utilized by neutrophils to kill disseminated tumor cells and to limit metastatic spread. Cancer Res; 78(10); 2680-90. ©2018 AACR .<br /> (©2018 American Association for Cancer Research.)

Details

Language :
English
ISSN :
1538-7445
Volume :
78
Issue :
10
Database :
MEDLINE
Journal :
Cancer research
Publication Type :
Academic Journal
Accession number :
29490946
Full Text :
https://doi.org/10.1158/0008-5472.CAN-17-3614